Inflammatory mediators in cystic fibrosis lung disease
- PMID: 11894730
Inflammatory mediators in cystic fibrosis lung disease
Abstract
Cystic fibrosis (CF) is a complex multisystem disorder caused by mutations in a membrane glycoprotein called the CF transmembrane regulator (CFTR), which has as its major function serving as a Cl- channel. The relationship between defects in CFTR and development of lung disease remains incompletely understood. Chronic lung disease, characterized by persistent infection with a peculiar type of Pseudomonas aeruginosa, bronchiectasis, and airway obstruction is the major cause of morbidity and mortality in CF patients. The inflammatory response to the chronic infection resembles that induced by lipopolysaccharide (LPS) and is mediated primarily by cytokines such as tumor necrosis factor (TNF), interleukin-1 (IL-1), IL-6, and IL-8, whose synthesis is activated by the transcription factor nuclear factor kappa B (NF-kappa B). Large numbers of neutrophils dominate the inflammatory response and excessive concentrations of their products create a vicious cycle that becomes injurious rather than protective and eventually claims the life of the patient.
Similar articles
-
The role of inflammation in the pathophysiology of CF lung disease.Clin Rev Allergy Immunol. 2002 Aug;23(1):5-27. doi: 10.1385/CRIAI:23:1:005. Clin Rev Allergy Immunol. 2002. PMID: 12162106 Review.
-
Chronic inflammation in the cystic fibrosis lung: alterations in inter- and intracellular signaling.Clin Rev Allergy Immunol. 2008 Apr;34(2):146-62. doi: 10.1007/s12016-007-8039-9. Clin Rev Allergy Immunol. 2008. PMID: 17960347 Review.
-
Role of IL-10 deficiency in excessive nuclear factor-kappaB activation and lung inflammation in cystic fibrosis transmembrane conductance regulator knockout mice.J Allergy Clin Immunol. 2005 Feb;115(2):405-11. doi: 10.1016/j.jaci.2004.10.044. J Allergy Clin Immunol. 2005. PMID: 15696103
-
Acute Pseudomonas challenge in cystic fibrosis mice causes prolonged nuclear factor-kappa B activation, cytokine secretion, and persistent lung inflammation.J Allergy Clin Immunol. 2006 May;117(5):1163-9. doi: 10.1016/j.jaci.2006.01.052. J Allergy Clin Immunol. 2006. PMID: 16675347
-
Cytokines and inflammatory mediators in cystic fibrosis.J Cyst Fibros. 2004 Dec;3(4):223-31. doi: 10.1016/j.jcf.2004.06.006. J Cyst Fibros. 2004. PMID: 15698939 Review.
Cited by
-
Fluorescent cellular assay for screening agents inhibiting Pseudomonas aeruginosa adherence.Sensors (Basel). 2015 Jan 16;15(1):1945-53. doi: 10.3390/s150101945. Sensors (Basel). 2015. PMID: 25602268 Free PMC article.
-
Development of a vaccine against Staphylococcus aureus invasive infections: Evidence based on human immunity, genetics and bacterial evasion mechanisms.FEMS Microbiol Rev. 2020 Jan 1;44(1):123-153. doi: 10.1093/femsre/fuz030. FEMS Microbiol Rev. 2020. PMID: 31841134 Free PMC article. Review.
-
A549 lung epithelial cells grown as three-dimensional aggregates: alternative tissue culture model for Pseudomonas aeruginosa pathogenesis.Infect Immun. 2005 Feb;73(2):1129-40. doi: 10.1128/IAI.73.2.1129-1140.2005. Infect Immun. 2005. PMID: 15664956 Free PMC article.
-
Th2 allergic immune response to inhaled fungal antigens is modulated by TLR-4-independent bacterial products.Eur J Immunol. 2009 Mar;39(3):776-88. doi: 10.1002/eji.200838932. Eur J Immunol. 2009. PMID: 19224641 Free PMC article.
-
Inhibition of tumor necrosis factor-alpha-induced RANTES secretion by alkaline protease in A549 cells.Am J Respir Cell Mol Biol. 2005 Nov;33(5):483-9. doi: 10.1165/rcmb.2005-0069OC. Epub 2005 Jul 21. Am J Respir Cell Mol Biol. 2005. PMID: 16037484 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical